| Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma I Janoueix-Lerosey, D Lequin, L Brugières, A Ribeiro, L De Pontual, ... Nature 455 (7215), 967-970, 2008 | 1034 | 2008 |
| Genomic Landscape of Ewing Sarcoma Defines an Aggressive Subtype with Co-Association of STAG2 and TP53 Mutations F Tirode, D Surdez, X Ma, M Parker, MC Le Deley, A Bahrami, Z Zhang, ... Cancer discovery 4 (11), 1342-1353, 2014 | 509 | 2014 |
| Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma D Williamson, E Missiaglia, A de Reynies, G Pierron, B Thuille, ... J Clin Oncol 28 (13), 2151-2158, 2010 | 483 | 2010 |
| A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion G Pierron, F Tirode, C Lucchesi, S Reynaud, S Ballet, S Cohen-Gogo, ... Nature genetics 44 (4), 461-466, 2012 | 467 | 2012 |
| Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries V Boeva, C Louis-Brennetot, A Peltier, S Durand, C Pierre-Eugène, ... Nature genetics 49 (9), 1408-1413, 2017 | 403 | 2017 |
| PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification E Missiaglia, D Williamson, J Chisholm, P Wirapati, G Pierron, F Petel, ... J Clin Oncol 30 (14), 1670-1677, 2012 | 320 | 2012 |
| SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas F Le Loarer, S Watson, G Pierron, VT de Montpreville, S Ballet, N Firmin, ... Nature genetics 47 (10), 1200-1205, 2015 | 295 | 2015 |
| Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types R Lebofsky, C Decraene, V Bernard, M Kamal, A Blin, Q Leroy, TR Frio, ... Molecular oncology 9 (4), 783-790, 2015 | 284 | 2015 |
| Transcriptomic definition of molecular subgroups of small round cell sarcomas S Watson, V Perrin, D Guillemot, S Reynaud, JM Coindre, M Karanian, ... The Journal of pathology 245 (1), 29-40, 2018 | 269 | 2018 |
| Impact of EWS-ETS Fusion Type on Disease Progression in Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor: Prospective Results From the … MC Le Deley, O Delattre, KL Schaefer, SA Burchill, G Koehler, ... Journal of Clinical Oncology 28 (12), 1982-1988, 2010 | 255 | 2010 |
| Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity A Vincent-Salomon, N Gruel, C Lucchesi, G MacGrogan, R Dendale, ... Breast Cancer Research 9, 1-15, 2007 | 227 | 2007 |
| Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor F Bourdeaut, D Lequin, L Brugieres, S Reynaud, C Dufour, F Doz, ... Clinical Cancer Research 17 (1), 31-38, 2011 | 226 | 2011 |
| DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma NC Sheffield, G Pierron, J Klughammer, P Datlinger, A Schönegger, ... Nature medicine 23 (3), 386-395, 2017 | 223 | 2017 |
| Emergence of New ALK Mutations at Relapse of Neuroblastoma G Schleiermacher, N Javanmardi, V Bernard, Q Leroy, J Cappo, ... Journal of Clinical Oncology 32 (25), 2727-2734, 2014 | 223 | 2014 |
| Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma S Postel-Vinay, AS Véron, F Tirode, G Pierron, S Reynaud, H Kovar, ... Nature genetics 44 (3), 323-327, 2012 | 207 | 2012 |
| Accumulation of segmental alterations determines progression in neuroblastoma G Schleiermacher, I Janoueix-Lerosey, A Ribeiro, J Klijanienko, ... Journal of Clinical Oncology 28 (19), 3122-3130, 2010 | 195 | 2010 |
| Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite TGP Grünewald, V Bernard, P Gilardi-Hebenstreit, V Raynal, D Surdez, ... Nature genetics 47 (9), 1073-1078, 2015 | 194 | 2015 |
| High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors E Manié, A Vincent-Salomon, J Lehmann-Che, G Pierron, E Turpin, ... Cancer research 69 (2), 663-671, 2009 | 192 | 2009 |
| Two types of chromosome 1p losses with opposite significance in gliomas A Idbaih, Y Marie, G Pierron, C Brennetot, K Hoang‐Xuan, M Kujas, ... Annals of neurology 58 (3), 483-487, 2005 | 187 | 2005 |
| Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study A Italiano, I Di Mauro, J Rapp, G Pierron, N Auger, L Alberti, F Chibon, ... The Lancet Oncology 17 (4), 532-538, 2016 | 179 | 2016 |
